These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 6765467)
1. Indomethacin treatment in patent ductus arteriosus. A double-blind study utilizing indomethacin plasma levels. Nestrud RM; Hill DE; Arrington RW; Beard AG; Dungan WT; Lau PY; Norton JB; Readinger RI Dev Pharmacol Ther; 1980; 1(2-3):125-36. PubMed ID: 6765467 [TBL] [Abstract][Full Text] [Related]
2. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study. Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841 [TBL] [Abstract][Full Text] [Related]
3. The use of ibuprofen in neonates in the treatment of patent ductus arteriosus. Van Overmeire B Int J Clin Pract Suppl; 2003 Apr; (135):23-7. PubMed ID: 12723743 [TBL] [Abstract][Full Text] [Related]
4. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels. O'Donovan DJ; Fernandes CJ; Nguyen NY; Adams K; Adams JM Am J Perinatol; 2004 May; 21(4):191-7. PubMed ID: 15168317 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. Mahony L; Carnero V; Brett C; Heymann MA; Clyman RI N Engl J Med; 1982 Mar; 306(9):506-10. PubMed ID: 7035955 [TBL] [Abstract][Full Text] [Related]
6. Indomethacin therapy in premature infants with patent ductus arteriosus--determination of therapeutic plasma levels. Yeh TF; Achanti B; Patel H; Pildes RS Dev Pharmacol Ther; 1989; 12(4):169-78. PubMed ID: 2766920 [TBL] [Abstract][Full Text] [Related]
7. Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus. Achanti B; Yeh TF; Pildes RS Clin Invest Med; 1986 Nov; 9(4):250-3. PubMed ID: 3802612 [TBL] [Abstract][Full Text] [Related]
8. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)]. Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus. Brash AR; Hickey DE; Graham TP; Stahlman MT; Oates JA; Cotton RB N Engl J Med; 1981 Jul; 305(2):67-72. PubMed ID: 7242577 [TBL] [Abstract][Full Text] [Related]
10. A double blind study of the effects of oral indomethacin in preterm infants with patent ductus arteriosus who failed medical management. Neu J; Ariagno RL; Johnson JD; Pitlick PT; Cohen RS; Beets CL; Sunshine P Pediatr Pharmacol (New York); 1981; 1(3):245-9. PubMed ID: 7346744 [TBL] [Abstract][Full Text] [Related]
11. Indomethacin for closure of patent ductus arteriosus in prematures. Mullett MD; Croghan TW; Myerberg DZ; Krall JM; Neal WA Clin Pediatr (Phila); 1982 Apr; 21(4):217-20. PubMed ID: 7039927 [TBL] [Abstract][Full Text] [Related]
12. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. Betkerur MV; Yeh TF; Miller K; Glasser RJ; Pildes RS Pediatrics; 1981 Jul; 68(1):99-102. PubMed ID: 6909683 [TBL] [Abstract][Full Text] [Related]
13. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. Supapannachart S; Limrungsikul A; Khowsathit P J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803 [TBL] [Abstract][Full Text] [Related]